📋 RUBIUS THERAPEUTICS, INC. (RUBY) - Clinical Trial Update
Filing Date: 2022-05-24
Accepted: 2022-05-24 08:05:39
Event Type: Clinical Trial Update
Event Details:
Rubius Therapeutics (company was delisted NASDAQ) (RUBY) Announces Clinical Trial Update
Rubius Therapeutics (company was delisted NASDAQ) (RUBY) provided an update on its clinical development programs.
Clinical Development Highlights:
Drug Program: results
Diseases/Conditions: RTX-240
Collaboration: Board of Directors
💼 Business Developments:
No business developments data available.
Structured Data:
Company Name: Rubius Therapeutics (company was delisted NASDAQ)
📋 RUBIUS THERAPEUTICS, INC. (RUBY) - Clinical Trial Update
Filing Date: 2022-05-24
Accepted: 2022-05-24 08:05:39
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
No business developments data available.
Structured Data: